SYT15

Chr 10

synaptotagmin 15

Also known as: CHR10SYT, sytXV

The protein encoded by SYT15 is involved in trafficking and exocytosis of secretory vesicles in non-neuronal tissues, functioning as a membrane trafficking protein with tandem C2 domains. Mutations cause autosomal recessive developmental and epileptic encephalopathy with onset in infancy, characterized by seizures, developmental delay, and intellectual disability. The gene is not highly constrained against loss-of-function variants.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
1
Pubs (1 yr)
45
P/LP submissions
0%
P/LP missense
1.78
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySYT15
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
45 unique Pathogenic / Likely Pathogenic· 89 VUS of 203 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.78LOEUF
pLI 0.000
Z-score -0.95
OE 1.26 (0.881.78)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.06Z-score
OE missense 1.01 (0.911.13)
228 obs / 225.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.26 (0.881.78)
00.351.4
Missense OE1.01 (0.911.13)
00.61.4
Synonymous OE1.03
01.21.6
LoF obs/exp: 20 / 15.9Missense obs/exp: 228 / 225.7Syn Z: -0.20
DN
0.6744th %ile
GOF
0.74top 25%
LOF
0.4234th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

203 submitted variants in ClinVar

Classification Summary

Pathogenic30
Likely Pathogenic15
VUS89
Likely Benign10
Benign45
30
Pathogenic
15
Likely Pathogenic
89
VUS
10
Likely Benign
45
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
30
0
30
Likely Pathogenic
0
0
15
0
15
VUS
0
73
16
0
89
Likely Benign
0
7
3
0
10
Benign
0
0
45
0
45
Total0801090189

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SYT15 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →